Biosimilar-Drugs
Biosimilar-Drugs
Latest Posts
-
Trastuzumab biosimilar (MYL-14010) shown effective in breast cancer clinical trial
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published…
You must be logged in to post a comment.